FAQ Directory

Here are some of the most frequently asked questions about NCQA’s various programs. If you don’t see what you are looking for in one of the entries below, you can  ask a question through My NCQA.

Filter Results
  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.

You are viewing a single FAQ from your previous search. Clear Search

expand all

12.28.2016 Proportion of Days Covered by Medications (PDC) Can you clarify the timeframe for the new Renin Angiotensin System (RAS) Antagonists denominator exclusion: “Patients dispensed at least one prescription for an ARB/Neprilysin Inhibitor Combination Medication (Table PDC-E)”?

The timeframe for this denominator exclusion should be any time during the treatment period and should read as follows:
 “Patients dispensed at least one prescription for an ARB/Neprilysin Inhibitor Combination Medication (Table PDC-E) any time during the treatment period.”

We will make this update for the next version of the VBP4P Manual.

ALL 2016